SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-20-000018
Filing Date
2020-08-12
Accepted
2020-08-12 16:21:33
Documents
58
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20200630.htm   iXBRL 10-Q 1634634
2 EX-31.1 exhibit311-condensed.htm EX-31.1 11670
3 EX-31.2 exhibit312-condensed.htm EX-31.2 11859
4 EX-32.1 exhibit321-condensed.htm EX-32.1 6657
5 EX-32.2 exhibit322-condensed.htm EX-32.2 6833
  Complete submission text file 0001764013-20-000018.txt   5870204

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20200630.xsd EX-101.SCH 34277
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20200630_cal.xml EX-101.CAL 62696
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20200630_def.xml EX-101.DEF 243248
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20200630_lab.xml EX-101.LAB 461541
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20200630_pre.xml EX-101.PRE 331434
11 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20200630_htm.xml XML 823557
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 201095713
SIC: 2836 Biological Products, (No Diagnostic Substances)